European Association for the Study of Diabetes 51st Annual Meeting

J Diabetes. 2016 Mar;8(2):177-80. doi: 10.1111/1753-0407.12352. Epub 2016 Jan 28.

Authors

Helen X Gao¹, Emily E Regier¹, Kelly L Close¹

Affiliation

¹ Close Concerns, San Francisco, California, USA.

PMID: 26606912
DOI: 10.1111/1753-0407.12352

No abstract available

Publication types

Congress
News

MeSH terms

Benzhydryl Compounds / therapeutic use
Canagliflozin / therapeutic use
Diabetes Mellitus, Type 1 / drug therapy*
Diabetes Mellitus, Type 1 / metabolism
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / metabolism
Glucosides / therapeutic use
Humans
Hypoglycemic Agents / therapeutic use*
Sodium-Glucose Transporter 2 / metabolism
Sodium-Glucose Transporter 2 Inhibitors*
Treatment Outcome

Substances

Benzhydryl Compounds
Glucosides
Hypoglycemic Agents
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors
Canagliflozin
empagliflozin